SynthesisObesity surgery2026
Time Trends in Thyroid Hormone Changes Following Bariatric Surgery: A Systematic Review and Meta-Analysis.
Synthesis in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Associations between thyroid axis changes and glycemic improvement after weight loss in type 2 diabetes: a mediation analysis.American journal of translational research · 2026Article
Corrections and comments
- Erratum issued
- Erratum issued
Authors and funding
7 authors.
Funding
Abstract
backgroundPreviouarch indicates varyings rese effects of bariatric surgery on thyroid function. This meta-analysis aims to evaluate time-dependent changes in thyroid hormone levels following bariatric surgery in patients with obesity.
methodsPubMed, Embase, and Scopus databases were systematically searched until July 2025 for observational studies including patients with obesity (body mass index ≥ 30 kg/m²) undergoing bariatric surgery, reporting changes in thyroid-stimulating hormone (TSH), free thyroxine (T4), or free triiodothyronine (T3) following surgery. A random-effects model was used for the meta-analysis, with meta-regression and subgroup analyses to evaluate the impact of age, sex, region, preoperative thyroid function, and surgery type on outcomes.
resultsA total of 57 studies with 8,030 participants were included. Significant reductions in TSH and FT3 levels were observed at 6-month (TSH: SMD: -1.43, 95% CI: -2.22 to -0.63; FT3: SMD: -1.89, 95% CI: -3.14 to -0.65) and 1-year (TSH: SMD: -1.38, 95% CI: -2.44 to -0.31; FT3: SMD: -2.14, 95% CI: -3.52 to -0.75). However, these reductions became non-significant at > 1-year follow-ups. No significant changes were observed in FT4 levels across all follow-up periods. Subgroup analyses indicated significant reductions in TSH and FT3 following sleeve gastrectomy, Roux-en-Y gastric bypass, and gastric banding, while bilio-pancreatic diversion did not result in significant hormone changes.
conclusionBariatric surgery leads to significant reductions in TSH and FT3 levels at 6-month and 1-year follow-ups, with no significant change in FT4 level. Further studies are needed to explore the mechanisms of thyroid changes after bariatric surgery and develop strategies to optimize thyroid health in these patients.
Indexed as
Identifiers
41654675What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.